Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
about
Routine administration of Anti-D: the ethical case for offering pregnant women fetal RHD genotyping and a review of policy and practice.The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis.Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study.From prenatal genomic diagnosis to fetal personalized medicine: progress and challenges.Recent advances in the prenatal interrogation of the human fetal genome.Haemolytic disease of the fetus and newborn.Routine testing of fetal Rhesus D status in Rhesus D negative women using cell-free fetal DNA: an investigation into the preferences and information needs of womenTargeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention programPre-analytical conditions in non-invasive prenatal testing of cell-free fetal RHDNon-Invasive Prenatal RHD Genotyping Using Cell-Free Fetal DNA from Maternal Plasma: An Italian Experience.Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus.Reliable Determination of Fetal RhD Status by RHD Genotyping from Maternal Plasma.Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran.Will the introduction of non-invasive prenatal testing for Down's syndrome undermine informed choice?Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands.Variants of RhD--current testing and clinical consequences.Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care.Anti-D prophylaxis: past, present and future.Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers.Noninvasive Prenatal Screening for Genetic Diseases Using Massively Parallel Sequencing of Maternal Plasma DNAConsiderations of red blood cell molecular testing in transfusion medicine.Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland.Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis.How to evaluate PCR assays for the detection of low-level DNA.Cell-free fetal DNA: the new tool in fetal medicineCosts and benefits of non-invasive fetal RhD determination.Use of cffDNA to avoid administration of anti-D to pregnant women when the fetus is RhD-negative: implementation in the NHS.Should cell-free DNA testing be used to target antenatal rhesus immune globulin administration?Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups.International reference reagents to standardise blood group genotyping: evaluation of candidate preparations in an international collaborative study.Non-invasive prenatal diagnosis from the perspective of a low-resource country.Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark.Noninvasive prenatal testing: the paradigm is shifting rapidly.Vox Sanguinis International Forum on application of fetal blood grouping: summary.Vox Sanguinis International Forum on application of fetal blood grouping.Noninvasive fetal RHD genotyping of RhD negative pregnant women for targeted anti-D therapy in Australia: A cost-effectiveness analysis.Guideline for blood grouping and red cell antibody testing in pregnancy.Consequences of being Rhesus D immunized during pregnancy and how to optimize new prevention strategies.Quantitative fetomaternal hemorrhage assessment with the use of five laboratory tests.Determination of Fetal RHD Genotype Including the RHD Pseudogene in Maternal Plasma.
P2860
Q27687533-3F7B3BF4-9AF2-4B30-B2E7-67B3E9991004Q30250029-865AAFA7-7EFE-4777-A02B-A665C4A169ABQ34132783-A65349BD-7995-4E5A-9F66-55429D92CB1AQ34286705-D4823EF7-BFF0-466E-9B68-44B8B33F824AQ34312211-A8C5312D-BBC6-4A8E-AA24-E0E627104B3BQ34472967-8B5A549D-05A0-42DB-9196-1B1AE303A38DQ34853996-82FAD4E1-AC6D-4D19-8F9F-97CD0ED7FD81Q34936608-BBCE3EA5-150B-4502-AB95-93CD2698F631Q35034936-EAE60CF8-17C2-4DD3-B02A-4DBB969D6B1FQ35507579-F22C164A-1F04-435C-93E9-CC4325DCE86CQ35977052-781F4FE6-01B0-4466-9960-4381C2368E86Q36794228-A6852895-F5D9-4CDF-89A5-A2A8F39BE6F3Q36837125-6D9A927A-D903-451E-97DF-343179BF3BC2Q37333449-9391F968-9AA3-478B-94A9-F712289398FFQ37397918-6D823663-F3C8-4423-84E9-9C206F8AC083Q38083742-5ABEC600-E281-49ED-BF8E-CD15385BF56EQ38178923-8C09D70D-274D-454D-AD96-7F32FECD2F0AQ38239704-CB8191F0-9C67-4F73-A54B-C9F5490B052AQ38459998-6EB42696-0AB8-4A99-8AE8-CDED4D034144Q38549770-1B068E2A-0C23-4A7B-839B-B45530F96C1CQ38586467-F83321FF-8CB8-4CC9-B06F-188CD08A531CQ38656110-45495454-DFED-4CBE-878B-805C98C02720Q38932336-42E8D334-A5CA-431B-924A-AF88205BD7BDQ40901636-84F59437-E8B1-41BF-B6E0-9FA6DDD6F917Q42393162-E45CA920-546B-4F2A-B2D1-7BA6BC132171Q43448023-AF28A0A0-2670-4209-8DD1-421C0B4E4DBFQ43476137-7E7EE8AC-F8D5-48F1-9336-7BC96A350FC0Q43605070-2AA8722F-03C6-4266-9271-D5878F83752BQ45984957-622DDBA3-6DEE-4A11-9680-A6B36A4CC6E8Q46046965-4BFE39C1-6F67-4D8C-B671-E3C357ED0AA0Q46118085-27E89A77-F06E-4E54-98F2-9D2EE2914560Q46227317-2C02E72B-8DEB-4995-BF23-A122F8F9B7B1Q48240788-C101F3C5-8186-48F8-9B30-8582C2E448E6Q48339570-57893272-0DAE-4F90-9438-2B8166D27485Q48339604-13E001EF-9A27-4A44-B7DF-925497C49136Q48374688-E169BB74-EA33-49F6-B49B-5BCB89CDC55EQ50244580-F800C127-6A2E-49A3-813F-90669467E659Q50489938-C3D083B3-ABBD-4E6A-94E9-4A1648943D30Q51694638-4238D32A-E0B7-4748-A5F9-4FB2CCA81FACQ51823244-031B7683-CA09-4E10-BA97-CF92D0CC5149
P2860
Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Report of the first nationally ...... for antenatal RhD prophylaxis.
@en
Report of the first nationally ...... for antenatal RhD prophylaxis.
@nl
type
label
Report of the first nationally ...... for antenatal RhD prophylaxis.
@en
Report of the first nationally ...... for antenatal RhD prophylaxis.
@nl
prefLabel
Report of the first nationally ...... for antenatal RhD prophylaxis.
@en
Report of the first nationally ...... for antenatal RhD prophylaxis.
@nl
P2093
P2860
P50
P1433
P1476
Report of the first nationally ...... for antenatal RhD prophylaxis.
@en
P2093
Christian Nielsen
Grethe Risum Krog
Karina Jensen
Keld Mikkelsen Homburg
Klaus Rieneck
Marianne Antonius Jakobsen
Niels Grunnet
Rikke Dyhrberg Madsen
Rudi Steffensen
Steffen Jørgensen
P2860
P304
P356
10.1111/J.1537-2995.2011.03362.X
P577
2011-10-13T00:00:00Z